--- title: "Moleac's NeuroAiD™II awarded Gold accreditation for clinical evidence and formulation uniqueness in Singapore." type: "News" locale: "en" url: "https://longbridge.com/en/news/274912005.md" description: "In Singapore on February 4, 2026, NeuroAiD™II received acknowledgment due to its strong clinical evidence and distinctive formulation. The recognition also emphasized the rigor of manufacturing, reproducibility, and quality control of NeuroAiD™II, underscoring its reliability and value in aiding support." datetime: "2026-02-05T03:51:15.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/274912005.md) - [en](https://longbridge.com/en/news/274912005.md) - [zh-HK](https://longbridge.com/zh-HK/news/274912005.md) --- # Moleac's NeuroAiD™II awarded Gold accreditation for clinical evidence and formulation uniqueness in Singapore. In Singapore on February 4, 2026, NeuroAiD™II received acknowledgment due to its strong clinical evidence and distinctive formulation. The recognition also emphasized the rigor of manufacturing, reproducibility, and quality control of NeuroAiD™II, underscoring its reliability and value in aiding support. ### Related Stocks - [MLECW.US](https://longbridge.com/en/quote/MLECW.US.md) - [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md) - [FBT.US](https://longbridge.com/en/quote/FBT.US.md) - [XBI.US](https://longbridge.com/en/quote/XBI.US.md) - [IBB.US](https://longbridge.com/en/quote/IBB.US.md) - [BBH.US](https://longbridge.com/en/quote/BBH.US.md) - [BIB.US](https://longbridge.com/en/quote/BIB.US.md) - [MLEC.US](https://longbridge.com/en/quote/MLEC.US.md) - [PBE.US](https://longbridge.com/en/quote/PBE.US.md) ## Related News & Research - [Wave Life Sciences posts positive RestorAATion-2 data; WVE-006 restores M-AAT, cuts Z-AAT, supports monthly dosing](https://longbridge.com/en/news/286818220.md) - [Roth MKM Sticks to Their Buy Rating for Capricor Therapeutics (CAPR)](https://longbridge.com/en/news/286497683.md) - [Full Transcript: Cellectar Biosciences Q1 2026 Earnings Call](https://longbridge.com/en/news/286422585.md) - [Genprex data shows gene therapy reverses hyperglycemia in T2D mice at ASGCT](https://longbridge.com/en/news/286414681.md) - [Regenxbio's muscle disorder therapy meets main goal in late-stage study](https://longbridge.com/en/news/286406339.md)